Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke.

Geoffrey A Donnan1, Marc Fisher, Malcolm Macleod

  • 1National Stroke Research Institute, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia. gdonnan@unimelb.edu.au

Lancet (London, England)
|May 13, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From the ASPREE investigators: Response to Wittes et al.

Clinical trials (London, England)·2025
Same author

Robotic Stroke Thrombectomy: A Feasibility and Efficacy Study in Flow Models.

Journal of stroke·2025
Same author

Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy.

Stroke·2025
Same author

Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last.

Stroke·2025
Same author

Costs and Benefits of the Melbourne Mobile Stroke Unit Compared With Standard Ambulance: Causal Analysis Using Observational Linked Data.

Stroke·2025
Same author

Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy: Post hoc analysis of the EOS individual participant data.

International journal of stroke : official journal of the International Stroke Society·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Stroke is a leading cause of death and disability, with increasing global burden. Advances in stroke care units, treatments like tissue plasminogen activator, and prevention strategies offer proven benefits.

Area of Science:

  • Neurology
  • Public Health
  • Gerontology

Background:

  • Stroke is the second leading cause of death and a major cause of disability globally.
  • The aging population is projected to significantly increase the burden of stroke, particularly in developing nations.
  • Recent advancements have improved stroke prevention and treatment over the last decade.

Purpose of the Study:

  • To review recent advances in stroke prevention and treatment.
  • To highlight the benefits of specialized stroke care units.
  • To identify challenges in global stroke care delivery.

Main Methods:

  • Review of current literature on stroke prevention and treatment strategies.
  • Analysis of interventions for acute stroke management.

Related Experiment Videos

  • Examination of secondary prevention measures for stroke survivors.

    • Main Results:

    • Effective interventions for acute stroke include stroke unit care, intravenous tissue plasminogen activator (within 3 hours), aspirin (within 48 hours), and decompressive surgery.
    • Proven secondary prevention strategies encompass warfarin for atrial fibrillation, carotid endarterectomy, antiplatelet agents, and cholesterol reduction.
    • Stroke care units are crucial for patient management and facilitate further research.

    Conclusions:

    • Significant progress has been made in stroke prevention and treatment.
    • Specialized stroke care units are vital for optimal patient outcomes and research.
    • A worldwide shortage of stroke healthcare workers, especially in developing countries, is a critical challenge.
    • Continued research and improved healthcare infrastructure are necessary to address the growing global burden of stroke.